Your browser doesn't support javascript.
loading
Impact of Anti-nuclear Antibody Seropositivity on Clinicopathological Parameters, Treatment Response, and Survival in Lymphoma Patients.
Kumar, Mahendra; Prakash, Gaurav; Bal, Amanjit; Kumari, Anu; Kumar, Yashwant; Bhardwaj, Ranjeet; Malhotra, Pankaj; Minz, Ranjana W.
Affiliation
  • Kumar M; Department of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Prakash G; Department of Clinical Hematology and Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Bal A; Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Kumari A; Department of Clinical Hematology and Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Kumar Y; Department of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Bhardwaj R; Department of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Malhotra P; Department of Clinical Hematology and Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Minz RW; Department of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Asian Pac J Cancer Prev ; 25(1): 73-78, 2024 Jan 01.
Article in En | MEDLINE | ID: mdl-38285769

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Lymphoma / Lymphoproliferative Disorders Type of study: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Asian Pac J Cancer Prev Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Lymphoma / Lymphoproliferative Disorders Type of study: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Asian Pac J Cancer Prev Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Country of publication: